Beranda › Melanoma
Uji klinis Melanoma yang merekrut di AS
197 studi untuk Melanoma merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- Houston, TX59 studi
- New York City, NY38 studi
- Los Angeles, CA34 studi
- Nashville, TN32 studi
- Pittsburgh, PA31 studi
- Boston, MA25 studi
- Philadelphia, PA23 studi
- San Francisco, CA22 studi
- Durham, NC21 studi
- Atlanta, GA21 studi
- Columbus, OH21 studi
- Salt Lake City, UT21 studi
- St. Louis, MO20 studi
- Dallas, TX20 studi
- Arlington, VA20 studi
- Tampa, FL19 studi
- Denver, CO19 studi
- San Diego, CA18 studi
- Aurora, CO18 studi
- Cincinnati, OH17 studi
- Seattle, WA17 studi
- Grand Rapids, MI17 studi
- Washington, DC17 studi
- Jacksonville, FL16 studi
- Rochester, MN16 studi
- Queens, NY16 studi
- Edison, NJ16 studi
- San Antonio, TX15 studi
- Orlando, FL15 studi
- Madison, WI15 studi
- Chicago, IL15 studi
- Portland, OR15 studi
- Orange, CA14 studi
- Cleveland, OH13 studi
- Minneapolis, MN12 studi
- Ann Arbor, MI12 studi
- Omaha, NE12 studi
- Detroit, MI11 studi
- Austin, TX11 studi
- Baltimore, MD11 studi
Berdasarkan negara bagian
- Alabama12 studi
- Alaska5 studi
- Arizona26 studi
- Arkansas13 studi
- California70 studi
- Colorado32 studi
- Connecticut14 studi
- Delaware6 studi
- Distrik Columbia7 studi
- Florida55 studi
- Georgia23 studi
- Hawaii3 studi
- Idaho8 studi
- Illinois22 studi
- Indiana14 studi
- Iowa12 studi
- Kansas15 studi
- Kentucky21 studi
- Louisiana9 studi
- Maine4 studi
- Maryland24 studi
- Massachusetts28 studi
- Michigan31 studi
- Minnesota29 studi
- Mississippi3 studi
- Missouri22 studi
- Montana8 studi
- Nebraska16 studi
- Nevada6 studi
- New Hampshire6 studi
- New Jersey24 studi
- New Mexico11 studi
- New York50 studi
- North Carolina31 studi
- North Dakota9 studi
- Ohio40 studi
- Oklahoma14 studi
- Oregon15 studi
- Pennsylvania47 studi
- Rhode Island5 studi
- South Carolina10 studi
- South Dakota6 studi
- Tennessee39 studi
- Texas77 studi
- Utah26 studi
- Vermont5 studi
- Virginia34 studi
- Washington25 studi
- West Virginia7 studi
- Wisconsin20 studi
- Wyoming3 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma
Menerima pesertaStudi observasionalSukarelawan sehat diterima
4 Weeks – 99 Years · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT00040352Neoadjuvant Ipilimumab/Nivolumab for Patients With Recurrent, High Risk, Resectable Melanoma
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06365619A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06172478The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07285044NeoAdjuvant, Spare-Adjuvant (NASA) in Stage IIIB-IV (M1a) Melanoma
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07740941Hepzato Kit and Opdualag for Metastatic Melanoma and Liver Metastasis
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT07281924A Study of BI 3810944 in Patients With Advanced Cancer
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT07224425A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT06961006Phase 1 Study of PF-08046033 in Advanced Solid Tumors
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07519655A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06246916Neoadjuvant Immune Checkpoint Blockade + a Prebiotic Food-enriched Dietary Intervention to Optimize Immune Response in Melanoma: NEO-PreFED
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06548789BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT05136196DESTINY-PANTUMOUR04
Menerima pesertaStudi observasional
Usia 18 hingga 130 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07124000Pan-tumor MRD Study
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06605404Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
Menerima pesertaFase 3
Usia 75 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT07068074Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06047379Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
Menerima pesertaFase 3
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT05727904A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information
Menerima pesertaFase 2
Hingga usia 25 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT07621614Bright Light Therapy in Patients With Melanoma or Non-small Cell Lung Cancer (NSCLC) Who Are Receiving First-Line Immune Checkpoint Blockade
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT07661966Intratumoral N17350 in Advanced Solid Tumors
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT07339176A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
Menerima pesertaFase 1
Usia 18 hingga 120 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06066138Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
Menerima pesertaFase 1/2
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06814496Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT06529822A Pilot Study of ctDNA-Guided Immune Checkpoint Inhibitor Duration in Patients With Advanced Melanoma.
Menerima peserta
Usia 18 hingga 90 · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT07830225R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid Tumors
Menerima pesertaFase 1
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT06398418Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.